Press release from Artimplant's Nomination Committee

Västra Frölunda, Sweden, March 11, 2008

In advance of Artimplant's Annual Meeting of Stockholders on May 6, 2008, Artimplant's Nomination Committee has decided to propose that Ingemar Kihlström, Lennart Ribohn, Anna Malm Bernsten and Wenche Rolfsen be re-elected as members of the Board of Directors. Rickard Söderberg declines re-election. The Nomination Committee has also decided to propose Mats Lindquist as a new member.

Mats Lindquist is Vice President, Global Business Development, NovaQuest. NovaQuest is the Partnering Group of Quintiles Transnational. Quintiles is a global CRO (Contract Research Organisation) with its core activities focused on clinical development and commercialization of pharmaceutical products. Mats Lindquist is a non executive Board member of BioPhausia AB.